In This Week's Update:
- CTSI KL2 Program Seeks Applications
- CTSI Stories: Do HIV Drugs Damage the Brain?
- Ever Better Mentoring - Hybrid Online Course for UR Faculty
- SAC Incubator Funding Program
- Community Engagement Symposium
- Community Engaged Research Conference
- Emergency Department Research Associate Program
- Improv for Faculty - Unlock Presentation Skills
- Annual Bioethics Lecture
- NCATS Stem Cell Workshop
- NCATS Pre-Clinical Development Proposals Due
- NCATS Funding Opportunity for UG3/UH3
- Calendar of Events
- Funding Opportunities
|
|
CTSI KL2 Career Development Program
Seeks Applications
The CTSI KL2 Career Development Program is accepting applications for KL2 awards to begin on June 1, 2018. The program provides two years of support for the early career development of multidisciplinary clinical and translational scientists. The goal of the program is to promote the successful transition of KL2 scholars to an independent career as a clinical and translational investigator, generally by means of an individual K or R award.
Read more about the program and find the Request for Applications (RFA) on the CTSI website.
Indications of Interest are due on October 2, 2017.
Applications are due on November 6, 2017.
|
|
Do Drugs that Keep HIV Patients Alive
Damage Their Brains?
Researchers from the University of Rochester Medical Center recently set out to understand whether drugs used to keep HIV patients alive could be damaging their brains. Early results from their clinical study suggest that these drugs do not pose a threat to the brain - at least in the short term.
Read the full article on the CTSI Stories Blog.
|
|
Ever Better Mentoring
Hybrid Online Course for UR Faculty
The CTSI, in conjunction with the Office of Faculty Development and Diversity, announce the hybrid online and face-to-face mentoring course, Ever Better Mentoring. The course is designed to both reinforce and introduce common issues faced by mentors of research trainees and students. Ever Better Mentoring includes a Blackboard™ component with videos and case-based scenarios, complemented by an in-person workshop to encourage exchange of best practices and persistent challenges. Both seasoned and inexperienced mentors have found the course valuable.
The course is open to all University of Rochester faculty; register through Blackboard. For questions please contact Oksana Babiy at Oksana_Babiy@urmc.rochester.edu.
|
|
Initial Abstracts Due for the
Scientific Advisory Committee (SAC)
Incubator Program
The School of Medicine and Dentistry’s Scientific Advisory Committee announces the 2017 request for applications (RFA) for the Incubator Program. The purpose of the program is to foster the establishment of extramurally funded interdisciplinary collaborations in biomedical research. The award has a maximum funding level of $125,000 per year for each of two years beginning July 1, 2018.
Initial abstracts are due on November 13, 2017.
For additional information and application instructions, click here.
|
|
Community Engagement Symposium
This interdisciplinary workshop is designed for students and instructors who want to conduct relevant community-engaged projects that are effective, evidence-based, measureable, and sustainable.
- Breakfast and networking
- Opening remarks by School of Nursing Dean, Kathy Rideout, EdD, PPCNP-BC, FNAP
- “A Current Picture of Rochester,” presented by Kate Washington, MBA, director of development services, Department of Neighborhood and Business Development, City of Rochester
- “Community Engagement Overview: Starting the Conversation,” led by Sady Fischer and Steve Jarose
- “Using and Contributing to the Evidence Base,” presented by Andy Aligne, MD, MPH
For additional information, contact Therese Green, PhD, MBA, director of community health, education, and policy; Center for Community Health, at: Theresa_Green@urmc.rochester.edu.
Date: Friday, September 8th
Time: 9:00 am – 12:00 pm
Location: School of Nursing, Helen Wood Hall (1-304)
|
|
Advancing the Science of Community Engaged Research Conference
This conference is hosted by Meharry Medical College, Vanderbilt University Medical Center, and the Association of American Medical Colleges (AAMC).
The Community Engaged Research Conference will convene researchers and community stakeholders in order to advance knowledge of the innovative methods and promising practices being used in the rapidly developing field of community engaged research. Learning labs will provide “how to” opportunities for small group learning on specific issues and practices, and think tanks will advance discussion and problem solving for issues that can impede or accelerate community engaged research.
Date: Thursday, September 14th and Friday, September 15th
Time: 7:30 am – 6:30 pm (Thursday)
7:30 am – 12:00 pm (Friday)
Location: Association of American Medical Colleges (AAMC)
655 K Street NW #100
Washington, DC 20001
202-828-0400
To register, click here. To reserve a hotel room, click here.
For additional information, please contact Indrani Singh at indrani_singh@urmc.rochester.edu.
|
|
Emergency Department
Research Associate (EDRA) Program
The Emergency Department Research Associate (EDRA) Program is a resource available to investigators who wish to access the more than 100,000 patients seen in the Strong Memorial Hospital Emergency Department each year. The program utilizes undergraduate enrollers from the University of Rochester, all of whom have completed thirty hours of rigorous classroom training, to screen and enroll patients in the Emergency Department between the hours of 8:00 am and 12:00 am seven days per week.
Enrollment can also be arranged in any of the Strong Hospital Urgent Care Centers in the Rochester area as well as the Highland Hospital Emergency Department. Now entering its 22nd year, the program has successfully screened and consented thousands of patients into dozens of clinical research study protocols of varying types and complexity.
The EDRA program operates under the umbrella of the Research Subjects Review Board’s (RSRB) approval for subject consent and enrollment. A full-time administrative staff, including a supervisor, administrative director, and PhD faculty director oversee the program. Robust quality assurance and quality improvement processes further ensure protocol compliance and documentation accuracy.
For more information or to receive a services quote to utilize the program, contact EDRA Supervisor, Joseph Glick at Joseph_Glick@urmc.rochester.edu.
|
|
Improv for Faculty
Unlock Your Presentation Skills
This workshop can help unlock the skills and techniques used by effective communicators. It will be taught by five academics with years of improv experience and specifically trained by the Alan Alda Institute in the use of improv for science communication. Through the use of fun, energizing, and interactive improv exercises, you will practice skills in a hands-on workshop to help internalize these powerful techniques.
Wear loose, comfortable clothing, and come ready to engage.
Learn more and reserve your space by contacting tracey_baas@urmc.rochester.edu by September 15th. Limited number of available spots.
Date: Monday, September 18th
Time: 9:00 am – 12:00 pm
Location: Rochester Institute of Technology
1 Lomb Memorial Drive
Rochester, NY 14623
|
|
Save the Date! 7th Annual Bioethics Lecture
“Do New Tools Need New Ethics? The Challenge of Governance for Gene Editing in Humans,” presented by Jeffrey Kahn, PhD, MPH, of the Berman Institute of Bioethics at Johns Hopkins University.
Date: Wednesday, September 27th
Time: 2:00 – 3:00 pm
Location: Class of ’62 Auditorium (G-9425)
Reception to follow in Natapow Conference Room (1-9545).
If you require accommodations for this event (for example, ASL Services), please contact GradAccessServices@urmc.rochester.edu at least three business days prior to the event.
|
|
NCATS Stem Cell
Translational Science Workshop
NCATS will host the Workshop on Translational Challenges of Induced Pluripotent Stem Cells (iPSC). The event will include discussions about iPSC collaborative opportunities and best practices in translational iPSC research.
Workshop Goals Include:
- Highlighting the biological and technological challenges of advancing iPSCs into clinical applications and drug discovery;
- Evaluating the state-of-the field of iPSC translation and discussing critical steps for quality control, standardization, and reproducibility;
- Discussing methods of protocol development/optimization and molecular and functional analyses;
- Seeking input from experts on areas of prioritization and tractable strategies for the iPSC field.
Date: Tuesday, September 26th
Time: 8:15 am – 5:00 pm
Location: National Institutes of Health
8600 Rockville Pike, Bethesda, MD 20894
Lister Hill National Center for Biomedical Communications
National Library of Medicine, Building 38A
Lister Hill Center Auditorium
For more information and registration: Website • Agenda • Register
|
|
Proposals Due for NCATS Collaborative
Pre-Clinical Development Programs
NCATS is accepting proposals to collaborate with its Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists.
BrIDGs scientists collaborate with researchers to advance candidate therapeutics for both common and rare diseases into clinical testing. TRND researchers and their collaborators move new therapeutic candidates through pre-clinical testing, from lead optimization to submission of an investigational new drug application.
Proposals are due September 30, 2017.
Learn how to collaborate with BrIDGs. Learn how to collaborate with TRND.
|
|
NCATS Funding Opportunity:
Bench Testing Therapeutic/Indication
Pairing Strategies (UG3/UH3)
This Funding Opportunity Announcement (FOA) invites applications for support of pre-clinical studies to repurpose existing experimental or FDA approved drugs or biologics (existing therapeutics) that have already begun or completed at least a Phase I trial.
The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include independent crowdsourcing strategies (such as, Industry-Provided Assets) or any website that lists experimental therapies, or use of computational algorithms.
The initial UG3 award will support the development of milestone-driven rigorous, pre-clinical target engagement and/or efficacy studies. Once UG3 pre-clinical milestones have been met, the UH3 award may be made to support clinical trial planning: this includes complete planning, design, and preparation of the documentation necessary for implementation of Phase I and/or Phase II clinical trials for a new therapeutic use.
The first application due date is October 30th.
|
|
|
|
|
